UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial

The lancet oncology, 2018-09, Vol.19 (9), p.1205-1214

2018

Volltextzugriff (PDF)

H. Hubert, « [Compte rendu de] G. Vacher de Lapouge. L’Aryen, son rôle social », L’Année sociologique, 1900

Anabases, 2017-11 (26), p.203-204

Hubert, Henri

2017

Volltextzugriff (PDF)

H. Hubert, « [Compte rendu de] G. Vacher de Lapouge. L’Aryen, son rôle social », L’Année sociologique, 1900

Anabases, 2017, p.203-204

Hubert, Henri

2017

Volltextzugriff (PDF)

Der Ursprung der magischen Kräfte in den australischen Gesellschaften. Analytisch-kritische Studie ethnographischer Dokumente

Trivium : revue franco-allemande de sciences humaines et sociales, 2014-10, Vol.17

2014

Volltextzugriff (PDF)

Thermal Disinfection Validation: The Relationship Between A 0 and Microbial Reduction

Biomedical instrumentation & technology, 2021-07, Vol.55 (3), p.85-90

2021

Volltextzugriff (PDF)

Thermal Disinfection Validation: The Relationship Between A0 and Microbial Reduction

Biomedical instrumentation & technology, 2021-07, Vol.55 (3), p.85-90

2021

Volltextzugriff (PDF)

Cosmetic Outcome Assessment following Breast-Conserving Therapy: A Comparison between BCCT.core Software and Panel Evaluation

International Journal of Breast Cancer, 2014-01, Vol.2014 (2014), p.177-183

2014

Volltextzugriff (PDF)

Bekoropoka: Quelques aspects de la vie familiale et sociale d'un village malgache

2019

Volltextzugriff (PDF)

EMBRACA: Efficacy outcomes in clinically relevant subgroups comparing talazoparib (TALA), an oral poly ADP ribose polymerase (PARP) inhibitor, to physician's choice of therapy (PCT) in patients with advanced breast cancer and a germline BRCA mutation

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1069-1069

2018

Volltextzugriff (PDF)

Analysis of germline BRCA1/2 m utated (g BRCA mut ) hormone receptor-positive (HR+) and triple negative breast cancer (TNBC) treated with talazoparib (TALA)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1070-1070

2018

Volltextzugriff (PDF)

Compliance with ASCO 2006 recommendations for the use of "white blood cell growth factors" in advanced lung cancer (LC) or breast cancer (BC) or non-Hodgkin lymphoma (NHL): An interim analysis of French National Observational Study—The ZOHé study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20663-e20663

2014

Volltextzugriff (PDF)

Could tumor growth rate provide useful information to predict the efficacy of eribulin?

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12028-e12028

2015

Volltextzugriff (PDF)

Biosimilar filgrastim treatment patterns and relative dose intensity (RDI) maintenance in patients receiving chemotherapy (CT) for the treatment of solid tumor (ST) or lymphoid malignancies (LM): A French national observational study (The ZOHé study)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20655-e20655

2015

Volltextzugriff (PDF)

Effect of high MMP2 and low MMP9 baseline serum levels on outcome in patients with HER2-positive inflammatory breast cancer (IBC) treated with bevacizumab (BEV)- and trastuzumab (TRA)-based neoadjuvant chemotherapy (NAC) in the BEVERLY 2 study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.600-600

2015

Volltextzugriff (PDF)

A phase 3, open-label, randomized, parallel, 2-arm international study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS1107-TPS1107

2015

Volltextzugriff (PDF)

Phase III study of vinflunine plus gemcitabine versus paclitaxel plus gemcitabine in the first-line treatment of anthracycline pretreated advanced breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.1011-1011

2014

Volltextzugriff (PDF)

Prediction of recurrence with the Onco type DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11052-11052

2014

Volltextzugriff (PDF)

Essai sur la nature et la fonction du sacrifice

Sociétés (Paris), 2010-06, Vol.n° 107 (1), p.63-71

2010

Volltextzugriff (PDF)

Exhaustive single nucleotide polymorphism (SNP) analysis of DPYD exome in breast cancer patients (pts) receiving capecitabine

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2571-2571

2015

Volltextzugriff (PDF)

Morphological explanation of high tear resistance of EPDM/NR rubber blends

Soft matter, 2017-06, Vol.13 (23), p.4241-4251

2017

Volltextzugriff (PDF)

Essay on the nature and function of sacrifice

Sociétés (Paris), 2010-01 (1), p.63-71

2010

Volltextzugriff (PDF)

Study of the expression of integrin pathway's proteins as predictive markers of response to neoadjuvant chemotherapy in pretreatment biopsies of patients with high-grade osteosarcoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10076-10076

2012

Volltextzugriff (PDF)

A French prospective pilot study for identifying dihydropyrimidine dehydrogenase (DPD) deficiency in breast cancer patients (pts) receiving capecitabine (cap)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e13519-e13519

2013

Volltextzugriff (PDF)

SOLTI NeoPARP: A phase II, randomized study of two schedules of iniparib plus paclitaxel and paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1011-1011

2012

Volltextzugriff (PDF)

Yersinia Enterocolitica: A Panoramic View of a Charismatic Microorganism

CRC critical reviews in microbiology, 1977, Vol.5 (2), p.211-241

1977

Volltextzugriff (PDF)

1 – 25 von 466

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(401)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(145)
Humans
(99)
Male
(67)
Biological And Medical Sciences
(64)
Female
(63)
Medical Sciences
(51)
Middle Aged
(49)
Life Sciences
(46)
Adult
(40)
Animals
(36)
Physical Sciences
(35)
Aged
(32)
Microbiology
(21)
Infectious Diseases
(20)
Chemistry
(19)
Pharmacology & Pharmacy
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
Pharmacology. Drug Treatments
(16)
Oncology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial

H. Hubert, « [Compte rendu de] G. Vacher de Lapouge. L’Aryen, son rôle social », L’Année sociologique, 1900

H. Hubert, « [Compte rendu de] G. Vacher de Lapouge. L’Aryen, son rôle social », L’Année sociologique, 1900

Der Ursprung der magischen Kräfte in den australischen Gesellschaften. Analytisch-kritische Studie ethnographischer Dokumente

Thermal Disinfection Validation: The Relationship Between A 0 and Microbial Reduction

Thermal Disinfection Validation: The Relationship Between A0 and Microbial Reduction

Cosmetic Outcome Assessment following Breast-Conserving Therapy: A Comparison between BCCT.core Software and Panel Evaluation

Bekoropoka: Quelques aspects de la vie familiale et sociale d'un village malgache

EMBRACA: Efficacy outcomes in clinically relevant subgroups comparing talazoparib (TALA), an oral poly ADP ribose polymerase (PARP) inhibitor, to physician's choice of therapy (PCT) in patients with advanced breast cancer and a germline BRCA mutation

Analysis of germline BRCA1/2 m utated (g BRCA mut ) hormone receptor-positive (HR+) and triple negative breast cancer (TNBC) treated with talazoparib (TALA)

Compliance with ASCO 2006 recommendations for the use of "white blood cell growth factors" in advanced lung cancer (LC) or breast cancer (BC) or non-Hodgkin lymphoma (NHL): An interim analysis of French National Observational Study—The ZOHé study

Could tumor growth rate provide useful information to predict the efficacy of eribulin?

Biosimilar filgrastim treatment patterns and relative dose intensity (RDI) maintenance in patients receiving chemotherapy (CT) for the treatment of solid tumor (ST) or lymphoid malignancies (LM): A French national observational study (The ZOHé study)

Effect of high MMP2 and low MMP9 baseline serum levels on outcome in patients with HER2-positive inflammatory breast cancer (IBC) treated with bevacizumab (BEV)- and trastuzumab (TRA)-based neoadjuvant chemotherapy (NAC) in the BEVERLY 2 study

A phase 3, open-label, randomized, parallel, 2-arm international study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA)

Phase III study of vinflunine plus gemcitabine versus paclitaxel plus gemcitabine in the first-line treatment of anthracycline pretreated advanced breast cancer

Prediction of recurrence with the Onco type DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial

Essai sur la nature et la fonction du sacrifice

Exhaustive single nucleotide polymorphism (SNP) analysis of DPYD exome in breast cancer patients (pts) receiving capecitabine

Morphological explanation of high tear resistance of EPDM/NR rubber blends

Essay on the nature and function of sacrifice

Study of the expression of integrin pathway's proteins as predictive markers of response to neoadjuvant chemotherapy in pretreatment biopsies of patients with high-grade osteosarcoma

A French prospective pilot study for identifying dihydropyrimidine dehydrogenase (DPD) deficiency in breast cancer patients (pts) receiving capecitabine (cap)

SOLTI NeoPARP: A phase II, randomized study of two schedules of iniparib plus paclitaxel and paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer (TNBC)

Yersinia Enterocolitica: A Panoramic View of a Charismatic Microorganism

Suchergebnisse filtern